800 / 1456
Select group of patients that benefit from aggressive local
treatment for oligometastatic disease
2y
63%
2y
57%
2y
86%
Sole CV, Lopez Guerra JL, et al. Clin Transl Oncol. 2013
Toxicity (N=28) Grade I
Grade II
Grade III
Pneumonitis
11
3
1
Chest wall pain
6
Skin
6
Esophagitis
3